- Home
- BZUN vs GALT Comparison
BZUN vs GALT Comparison
Compare BZUN & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- GALT
- Stock Information
- Founded
- BZUN 2007
- GALT 2000
- Country
- BZUN China
- GALT United States
- Employees
- BZUN N/A
- GALT N/A
- Industry
- BZUN Catalog/Specialty Distribution
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- BZUN Consumer Discretionary
- GALT Health Care
- Exchange
- BZUN Nasdaq
- GALT Nasdaq
- Market Cap
- BZUN 143.5M
- GALT 147.8M
- IPO Year
- BZUN N/A
- GALT N/A
- Fundamental
- Price
- BZUN $3.21
- GALT $2.08
- Analyst Decision
- BZUN Strong Buy
- GALT Strong Buy
- Analyst Count
- BZUN 3
- GALT 1
- Target Price
- BZUN $3.20
- GALT $11.00
- AVG Volume (30 Days)
- BZUN 927.9K
- GALT 549.5K
- Earning Date
- BZUN 11-21-2024
- GALT 11-13-2024
- Dividend Yield
- BZUN N/A
- GALT N/A
- EPS Growth
- BZUN N/A
- GALT N/A
- EPS
- BZUN N/A
- GALT N/A
- Revenue
- BZUN $1,312,737,613.00
- GALT N/A
- Revenue This Year
- BZUN $7.63
- GALT N/A
- Revenue Next Year
- BZUN $5.15
- GALT N/A
- P/E Ratio
- BZUN N/A
- GALT N/A
- Revenue Growth
- BZUN 7.26
- GALT N/A
- 52 Week Low
- BZUN $1.90
- GALT $1.56
- 52 Week High
- BZUN $4.38
- GALT $4.27
- Technical
- Relative Strength Index (RSI)
- BZUN 57.56
- GALT 38.64
- Support Level
- BZUN $2.65
- GALT $1.99
- Resistance Level
- BZUN $3.77
- GALT $2.36
- Average True Range (ATR)
- BZUN 0.28
- GALT 0.22
- MACD
- BZUN 0.10
- GALT -0.02
- Stochastic Oscillator
- BZUN 59.42
- GALT 24.14
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.